Sign in

CIK 0001570562 · Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461385614
Phone
(949) 284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market buy 10% owner bought 142,000 shares at an average $11.10 ($1,576,808)
  2. 4 Open-market buy 10% owner bought 103,000 shares at an average $10.53 ($1,084,808)
  3. 4 Open-market sale Director sold 61,840 shares at an average $10.59 ($654,871)
  4. 4 Open-market sale Director sold 67,083 shares at an average $10.20 ($684,561)
  5. 4 Open-market buy 10% owner bought 115,000 shares at an average $10.63 ($1,222,137)
  6. 4 Open-market sale See Remarks sold 70,445 shares at an average $11.13 ($783,810)
  7. 4 Open-market buy 10% owner bought 114,714 shares at an average $11.18 ($1,282,751)
  8. 4 Open-market buy 10% owner bought 65,286 shares at an average $10.87 ($709,452)
  9. 4/A Open-market sale Chief Marketing Officer sold 5,362 shares at $11.18 ($59,944)
  10. 4/A Open-market sale See Remarks sold 14,293 shares at $11.18 ($159,774)
  11. 4/A Open-market sale See Remarks sold 41,763 shares at $11.18 ($466,839)
  12. 4 Open-market sale See Remarks sold 14,293 shares at $11.18 ($159,774)
  13. 4 Open-market sale See Remarks sold 14,293 shares at $11.18 ($159,789)
  14. 4 Open-market sale Chief Marketing Officer sold 5,362 shares at $11.18 ($59,944)
  15. 4 Open-market sale See Remarks sold 41,763 shares at $11.18 ($466,839)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Shareholder vote results
  19. 10-Q Report Quarterly Report
  20. 8-K Event Acquisition or sale completed

Page 16 of 28 · 558 filings